Arcturus Therapeutics Holdings Stock Price History
| ARCT Stock | USD 16.91 0.16 0.94% |
Below is the normalized historical share price chart for Arcturus Therapeutics Holdings extending back to May 22, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcturus Therapeutics stands at 16.91, as last reported on the 24th of November, with the highest price reaching 17.50 and the lowest price hitting 16.20 during the day.
If you're considering investing in Arcturus Stock, it is important to understand the factors that can impact its price. Arcturus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0684, which signifies that the company had a -0.0684% return per unit of standard deviation over the last 3 months. Arcturus Therapeutics Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcturus Therapeutics' mean deviation of 3.11, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
At this time, Arcturus Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 28 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 1.5 M in 2024. . At this time, Arcturus Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.17 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.06 in 2024. Arcturus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2020 | 200 Day MA 26.5658 | 50 Day MA 20.2244 | Beta 2.64 |
Arcturus |
Sharpe Ratio = -0.0684
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARCT |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcturus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcturus Therapeutics by adding Arcturus Therapeutics to a well-diversified portfolio.
Price Book 1.7492 | Enterprise Value Ebitda (25.67) | Price Sales 2.8557 | Shares Float 24.8 M | Wall Street Target Price 79.4678 |
Arcturus Therapeutics Stock Price History Chart
There are several ways to analyze Arcturus Stock price data. The simplest method is using a basic Arcturus candlestick price chart, which shows Arcturus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 2, 2024 | 25.48 |
| Lowest Price | November 15, 2024 | 16.02 |
Arcturus Therapeutics November 24, 2024 Stock Price Synopsis
Various analyses of Arcturus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Arcturus Stock. It can be used to describe the percentage change in the price of Arcturus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Arcturus Stock.| Arcturus Therapeutics Price Daily Balance Of Power | (0.12) | |
| Arcturus Therapeutics Price Action Indicator | (0.02) | |
| Arcturus Therapeutics Price Rate Of Daily Change | 0.99 |
Arcturus Therapeutics November 24, 2024 Stock Price Analysis
Arcturus Stock Price History Data
The price series of Arcturus Therapeutics for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 9.46 with a coefficient of variation of 9.98. The prices are distributed with arithmetic mean of 20.24. The median price for the last 90 days is 20.61. The company had 1:7 stock split on 16th of November 2017. Arcturus Therapeutics issued dividends on 2017-11-16.| Open | High | Low | Close | Volume | ||
11/24/2024 | 17.01 | 17.50 | 16.20 | 16.91 | ||
| 11/22/2024 | 17.01 | 17.50 | 16.20 | 16.91 | 523,236 | |
| 11/21/2024 | 16.22 | 17.30 | 15.50 | 17.07 | 407,729 | |
| 11/20/2024 | 17.94 | 17.94 | 15.94 | 16.17 | 448,741 | |
| 11/19/2024 | 16.27 | 18.09 | 16.18 | 18.06 | 646,775 | |
| 11/18/2024 | 16.08 | 17.37 | 15.71 | 16.27 | 939,607 | |
| 11/15/2024 | 18.00 | 18.00 | 14.93 | 16.02 | 1,208,668 | |
| 11/14/2024 | 19.20 | 19.57 | 18.30 | 18.34 | 402,960 | |
| 11/13/2024 | 19.43 | 20.01 | 19.13 | 19.18 | 286,074 | |
| 11/12/2024 | 20.00 | 20.07 | 18.90 | 19.58 | 534,725 | |
| 11/11/2024 | 20.25 | 21.61 | 20.12 | 20.37 | 672,259 | |
| 11/08/2024 | 19.50 | 19.93 | 18.81 | 19.63 | 386,629 | |
| 11/07/2024 | 18.87 | 19.28 | 18.54 | 18.74 | 370,977 | |
| 11/06/2024 | 19.14 | 19.30 | 17.73 | 18.33 | 860,525 | |
| 11/05/2024 | 17.71 | 18.40 | 17.26 | 18.35 | 329,997 | |
| 11/04/2024 | 18.16 | 18.30 | 17.53 | 17.82 | 220,927 | |
| 11/01/2024 | 18.09 | 18.36 | 17.50 | 18.00 | 317,940 | |
| 10/31/2024 | 18.31 | 18.35 | 17.66 | 17.73 | 330,998 | |
| 10/30/2024 | 18.88 | 19.01 | 18.14 | 18.39 | 197,876 | |
| 10/29/2024 | 19.26 | 19.36 | 18.91 | 19.12 | 273,012 | |
| 10/28/2024 | 19.09 | 20.13 | 18.78 | 19.57 | 218,978 | |
| 10/25/2024 | 19.04 | 19.57 | 18.62 | 18.95 | 172,917 | |
| 10/24/2024 | 20.10 | 20.10 | 18.67 | 19.00 | 323,791 | |
| 10/23/2024 | 19.71 | 20.36 | 19.35 | 20.00 | 267,347 | |
| 10/22/2024 | 20.69 | 20.71 | 19.67 | 19.79 | 215,530 | |
| 10/21/2024 | 20.98 | 21.20 | 20.44 | 20.88 | 411,490 | |
| 10/18/2024 | 20.78 | 21.17 | 20.47 | 21.15 | 248,653 | |
| 10/17/2024 | 20.43 | 20.67 | 19.44 | 20.60 | 388,676 | |
| 10/16/2024 | 21.05 | 21.86 | 20.61 | 20.63 | 258,506 | |
| 10/15/2024 | 20.63 | 21.10 | 20.00 | 20.97 | 259,725 | |
| 10/14/2024 | 21.34 | 21.45 | 20.46 | 20.92 | 295,271 | |
| 10/11/2024 | 20.37 | 21.87 | 20.15 | 21.46 | 366,457 | |
| 10/10/2024 | 21.57 | 21.72 | 20.44 | 20.61 | 377,347 | |
| 10/09/2024 | 22.33 | 22.36 | 21.44 | 21.89 | 293,653 | |
| 10/08/2024 | 23.68 | 23.85 | 22.45 | 22.47 | 212,476 | |
| 10/07/2024 | 23.71 | 24.13 | 22.93 | 23.87 | 267,421 | |
| 10/04/2024 | 24.91 | 25.38 | 23.51 | 23.88 | 215,611 | |
| 10/03/2024 | 25.10 | 25.42 | 24.12 | 24.76 | 352,589 | |
| 10/02/2024 | 25.31 | 25.88 | 24.57 | 25.48 | 400,780 | |
| 10/01/2024 | 22.96 | 25.31 | 21.99 | 25.25 | 646,414 | |
| 09/30/2024 | 21.69 | 23.55 | 21.55 | 23.21 | 421,663 | |
| 09/27/2024 | 22.17 | 22.37 | 21.74 | 22.03 | 371,323 | |
| 09/26/2024 | 21.72 | 21.79 | 21.10 | 21.77 | 274,122 | |
| 09/25/2024 | 21.73 | 21.96 | 20.89 | 21.31 | 334,953 | |
| 09/24/2024 | 21.16 | 21.96 | 21.12 | 21.74 | 339,180 | |
| 09/23/2024 | 20.61 | 21.66 | 20.50 | 21.15 | 499,918 | |
| 09/20/2024 | 20.88 | 21.50 | 20.39 | 20.61 | 572,776 | |
| 09/19/2024 | 21.23 | 21.70 | 20.94 | 21.02 | 300,018 | |
| 09/18/2024 | 20.80 | 21.55 | 20.05 | 20.55 | 429,083 | |
| 09/17/2024 | 21.02 | 21.99 | 20.62 | 21.01 | 418,204 | |
| 09/16/2024 | 20.96 | 21.41 | 20.10 | 20.61 | 331,430 | |
| 09/13/2024 | 20.22 | 20.87 | 19.97 | 20.75 | 586,234 | |
| 09/12/2024 | 20.95 | 21.00 | 19.53 | 19.91 | 382,924 | |
| 09/11/2024 | 19.58 | 21.02 | 19.25 | 20.98 | 546,552 | |
| 09/10/2024 | 19.05 | 19.85 | 18.92 | 19.76 | 242,911 | |
| 09/09/2024 | 18.75 | 19.25 | 18.55 | 19.00 | 358,082 | |
| 09/06/2024 | 18.64 | 18.91 | 18.11 | 18.69 | 292,049 | |
| 09/05/2024 | 19.06 | 19.31 | 18.69 | 18.82 | 392,455 | |
| 09/04/2024 | 19.47 | 19.98 | 18.94 | 19.06 | 389,796 | |
| 09/03/2024 | 21.02 | 21.96 | 19.20 | 19.39 | 455,365 | |
| 08/30/2024 | 21.07 | 21.35 | 20.59 | 21.10 | 261,753 |
About Arcturus Therapeutics Stock history
Arcturus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcturus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcturus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcturus Therapeutics stock prices may prove useful in developing a viable investing in Arcturus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 28 M | |
| Net Income Applicable To Common Shares | 8.4 M | 8.8 M |
Arcturus Therapeutics Quarterly Net Working Capital |
|
Arcturus Therapeutics Stock Technical Analysis
Arcturus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Arcturus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcturus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcturus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcturus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (0.93) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arcturus Stock Analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.